Screener
Moderna MRNA EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
The source filing: Moderna’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001682852-26-000060
FAQ
- What is Moderna's EBITDA?
- Moderna (MRNA) reported EBITDA of -$1.33B in Q1 2026.
- How has Moderna's EBITDA changed year-over-year?
- Moderna's EBITDA decreased by 31.5% year-over-year, from -$1.01B to -$1.33B.
- What is the long-term trend for Moderna's EBITDA?
- Over 4 years (2021 to 2025), Moderna's EBITDA has grown at a -32.2% compound annual growth rate (CAGR), from $13.53B to -$2.86B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Moderna's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude